A crowd crush at a Hindu chariot festival in eastern India leaves at least one person dead and around 100 others injured, according to reports. The incident occurs when a surge of people moves suddenly through the festival grounds, causing people to fall and be trampled. Emergency responders move injured attendees to nearby hospitals. The reports describe the scale of the impact, noting that many people require medical treatment and that the situation prompts a response from local emergency services. While the accounts agree on the outcome—one death and roughly a hundred people hurt—they provide limited detail on the exact location of the festival, the circumstances leading to the surge, or the condition of the injured. Authorities are not described in the available summaries as having announced specific findings beyond treating casualties and responding to the crush. The incident highlights the risk of crowd density during major religious events.
One dead and about 100 hurt after crowd crush at Hindu chariot festival in eastern India
A crowd crush at a Hindu chariot festival in eastern India leaves at least one person dead and around 100 others injured, according to reports. The incident occurs when a surge of people moves suddenl...
- A crowd surge at a Hindu chariot festival in eastern India causes a crush.
- At least one person dies.
- About 100 people are injured and taken to hospital.
- The reports describe emergency medical response following the incident.
- The summaries provide limited information on causes beyond the sudden surge of the crowd.
A sudden crowd surge at a Hindu festival in eastern India has left at least one person dead and many hospitalised.
3 hours agoA sudden crowd surge at a Hindu festival in eastern India has left at least one person dead and many hospitalised.
3 hours agoLendlease fund sells Little Collins Street office for under half its post-pandemic price
A Lendlease-managed fund sells a B-grade office building on Little Collins Street in Melbourne for less than half the pr...
China performs world’s first commercial implant of an invasive brain-computer interface device
China completes what multiple outlets describe as the world’s first commercial implantation of an invasive brain-compute...
FDA approves Merck’s once-daily Lipfendra, a new oral PCSK9 inhibitor for high LDL
The U.S. Food and Drug Administration has approved Lipfendra, Merck’s once-daily oral cholesterol-lowering medication fo...